Swiss scientists have created an implantable molecular device with a sensor that measures blood pH levels and a gene feedback mechanism that produces the necessary amount of insulin if acidosis becomes a risk for type 1 diabetes patients. The molecular device was designed using various genes and proteins, and comprises a …

In a study using data from 5 million patients, researchers found that obese or overweight individuals had a higher risk of developing 10 common cancers. Leukemia and cancers of the uterus, gallbladder, kidney, cervix and thyroid rose linearly along with weight. Higher BMI was associated with a greater risk of …

The US Food and Drug Administration has approved Invokamet, a fixed-dose therapy combining Invokana (canagliflozin) and metformin…. Invokana, a member of the new class of drugs known as sodium glucose co-transporter 2 (SGLT2) inhibitors, was approved in the USA as a single agent in March 2013. The thumbs-up is based …

A study involving over 180,000 people showed that patients treated with metformin can live longer than non-diabetics…. 

Control solution, used for ensuring the proper function of glucose meters, doesn’t appear to be a priority among physicians, pharmacists, or patients…. 

One researcher comments, "Please don’t fall into this trap that you can prevent diabetes with insulin."…

How can three landmark trials of intensive vs standard glucose-lowering strategies — ADVANCE, ACCORD, and VADT — raise more questions than they answer?… 

Testing for peripheral neuropathy may provide a way to identify individuals at higher risk of cardiovascular events…. 

Study seems to indicate superiority of dulaglutide, a long-acting GLP-1 receptor agonist that is administered once-weekly…. 

The effects of caffeine versus maltodextrin during exercise were observed in patients with type 2 diabetes….